Racheal Bailey, PharmD, MBA, BCCP

ED Pharmacist. @ Duke Regional Hospital, @UTPharmacy ‘20, PGY2 Cardiology Resident @ UNC Rex, PGY1 @ AscensionSTHW

[CVCSCCM @CVCSCCM]

#EMPULSE found initiation of empagliflozin in hospitalized acute HF patients resulted in a meaningful improvement in quality of life as well as a reduction in all-cause mortality and heart failure events. #cvcsccmjc

[Patrick Holmes @drpatrickholmes]

What should be the first-line METFORMIN or SGLT2i❓
Data from @AnnalsofIM / @BrighamWomens
ANSWER = SGLT2i
⚠️ Observational Date
📍Large 🇺🇸 database
✅ Propensity matched

SGLT2i vs Met
⤵️ 💔🏥/💔☠️
↔️ MI/Stroke (3P MACE)

#CaReMe #T2D

https://t.co/Wi5IXjq5EO

@kamleshkhunti

[CVCSCCM @CVCSCCM]

Are SGLT2 inhibitors safe and effective in patients hospitalized for acute heart failure? Join us for the #cvcsccmjc in 2 hours to learn more. #EMPULSE

[CVCSCCM @CVCSCCM]

Join us tomorrow at 8pm EST for the next CVCSCCM Twitter Journal club led by Racheal Bailey, PGY2 Cards Pharmacy resident @ UNC Rex! We will be discussing the EMPULSE trial! Visual abstract is attached below, hope to see you there! #CVCSCCMjc